DEL FABRO, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 370
AS - Asia 331
EU - Europa 150
SA - Sud America 118
AF - Africa 10
Totale 979
Nazione #
US - Stati Uniti d'America 356
SG - Singapore 136
BR - Brasile 102
HK - Hong Kong 86
IT - Italia 41
VN - Vietnam 41
FR - Francia 26
DE - Germania 21
CN - Cina 20
IE - Irlanda 17
GB - Regno Unito 13
CA - Canada 10
IN - India 9
AR - Argentina 7
AT - Austria 7
TR - Turchia 7
BD - Bangladesh 6
NL - Olanda 5
CL - Cile 4
IL - Israele 4
ZA - Sudafrica 4
ES - Italia 3
ID - Indonesia 3
IQ - Iraq 3
MX - Messico 3
PL - Polonia 3
AZ - Azerbaigian 2
CO - Colombia 2
EE - Estonia 2
EG - Egitto 2
FI - Finlandia 2
LT - Lituania 2
RU - Federazione Russa 2
SE - Svezia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
EC - Ecuador 1
ET - Etiopia 1
GD - Grenada 1
HR - Croazia 1
JP - Giappone 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MA - Marocco 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UA - Ucraina 1
VE - Venezuela 1
Totale 979
Città #
Dallas 224
Hong Kong 86
Singapore 65
The Dalles 26
Ashburn 21
Ho Chi Minh City 21
Florence 20
Dublin 17
Assago 8
Beijing 8
Frankfurt am Main 8
Santa Clara 8
São Paulo 8
Düsseldorf 6
Hanoi 6
Istanbul 5
New York 5
Rome 5
San Francisco 5
Bexley 4
Brooklyn 4
Los Angeles 4
Baghdad 3
Charlotte 3
Chicago 3
Da Nang 3
London 3
Manchester 3
Milan 3
Abbotsford 2
Atlanta 2
Baku 2
Belo Horizonte 2
Brasília 2
Cape Town 2
Catania 2
Diadema 2
Fortaleza 2
Haiphong 2
Independencia 2
Lauterbourg 2
Lençóis Paulista 2
Newark 2
Nuremberg 2
Orem 2
Pune 2
Rio de Janeiro 2
Tashkent 2
Tel Aviv 2
Wroclaw 2
Abu Dhabi 1
Adana 1
Addis Ababa 1
Agudos 1
Ahmedabad 1
Albox 1
Alegre 1
Alto Araguaia 1
Amsterdam 1
Ananindeua 1
Ankara 1
Anápolis 1
Aquiraz 1
Aracaju 1
Araçatuba 1
As Sālimīyah 1
Barcelona 1
Barra Mansa 1
Beirut 1
Belém 1
Berlin 1
Betim 1
Bishkek 1
Biên Hòa 1
Bogotá 1
Bom Jardim de Goiás 1
Boston 1
Bragança 1
Buffalo 1
Cabreúva 1
Cachoeirinha 1
Calgary 1
Campinas 1
Campo Bom 1
Campo Mourão 1
Can Tho 1
Candelária 1
Canindé de São Francisco 1
Capão da Canoa 1
Caraguatatuba 1
Carapicuíba 1
Castelo do Piauí 1
Catu 1
Changsha 1
Chapecó 1
Chittagong 1
Concepción 1
Contagem 1
Curitiba 1
Dakar 1
Totale 677
Nome #
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape 57
Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia 54
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over 52
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 51
Feasibility, tolerability and efficacy of carfilzomib in combination with lenalidomide and dexamethasone in relapsed refractory myeloma patients: A retrospective real-life survey of the sicilian myeloma network 50
Serum free light chains and multiple myeloma: Is it time to extend their application? 43
Multiple Myeloma in 2023 Ways: From Trials to Real Life 42
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones? 41
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions 41
IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia 41
Chemotherapy extravasation: diagnosis, prevention and management 40
Emergencies in Hematology: Why, When and How I Treat? 40
IgG-k/IgG-λ Para-Osseous Plasmacytoma Relapsed as Soft-Tissue Plasmacytoma with IgA-k Immunophenotype: A Case Report and Review of the Literature on Related Biochemical Aspects 37
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 36
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 34
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study 34
Lenalidomide and pomalidomide improve function and induce fcγri/cd64 in multiple myeloma neutrophils 32
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 32
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey 32
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies 30
Clinical benefit of long-term disease control with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients 30
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 29
Role of serum free light chain assay in relapsed/refractory multiple myeloma. A real‐life unicentric retrospective study 27
Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network 25
Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review 25
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection 24
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment 18
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy 12
Diffuse large B-cell lymphoma in the new era: prognostic tools for mapping risk 8
Totale 1.017
Categoria #
all - tutte 4.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025445 0 0 0 7 10 95 31 80 41 79 66 36
2025/2026572 71 167 161 105 54 14 0 0 0 0 0 0
Totale 1.017